Medtide proposes bylaw changes to allow board size range of five to nine directorsPUBT·12 hours ago03880+0.36%
Medtide proposes 10-year RSU incentive scheme with 14,180,000-share mandate limitPUBT·12 hours ago03880+0.36%
Medtide H1 FY26 profit drops 47.4% to RMB 53.68 million; revenue falls 7.6% to RMB 234.52 millionPUBT·12 hours ago03880+0.36%
The Market's Misfits: Why 9 Overlooked Hong Kong Stocks Tell a Bigger StoryGlobal Report·2 days ago, 06:33 AM02883+0.83%01798+3.45%
Market Unbundling: From Narrative Arbitrage to Physical Value ChainsGlobal Report·2 days ago, 04:21 AMHOLO+3.28%03880+0.36%
Real Estate's AI Pivot and Macau's Summer Slump: Moves in HK FringesGlobal Report·Aug 11 at 04:43 AM01592+5.41%06687+2.20%
Hong Kong's Micro-Divergence: From JNBY's Breakout to Traditional Consumption PainsGlobal Report·Aug 6 at 04:15 AM026050.00%03306-0.05%
Medtide unit Chinese Peptide completes US FDA pre-license inspection for Hepcludex API facilityPUBT·Jul 31 at 03:35 AM03880+0.36%
Medtide expects H1 profit to fall 44%-52% to RMB 49.4 million-RMB 57.1 millionPUBT·Jul 31 at 03:33 AM03880+0.36%
Niche Hong Kong Equities See Independent Catalysts From On-Device AI to Aviation Fleet ExpansionGlobal Report·Jul 30 at 04:14 AM03268+1.61%02665-2.12%
HK Niche Leaders Push Forward With Key Expansions and IPOsGlobal Report·Jul 22 at 04:17 AM01318-1.29%01180-17.02%
Medtide amends articles of association, scraps supervisory committeePUBT·Jun 18 at 06:29 AM03880+0.36%
Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality ConcernsSimplywall·Mar 31 at 08:46 AM520500+0.61%513120+0.74%
